Sinapis Pharma's Series A Round

Sinapis Pharma raised a round of funding on November 12, 2009.

Sinapis Pharma is a discovery stage biotechnology company that has identified and has patents-pending for a new use and route of administration for its lead compound, Methamphetamine, an FDA-approved …

Articles about Sinapis Pharma's Series A Round: